Dr. Carolyn Brockington: The Truth About the New “Smart Drugs”
Smart drugs, also known as nootropics, are popular with Silicon Valley CEOs, millennials and college kids, catering to anyone that wants to have “a better brain.” Some promise scientifically-tested results and almost all have a money-back guarantee. But these claims have not been evaluated by the FDA. Carolyn Brockington, MD, Director, The Stroke Center, Mount Sinai Roosevelt and Mount Sinai St. Luke’s, told Dr. Oz that “the real concern lies in the effectiveness of these pills and what the long-term effects may be. Many pills have not undergone rigorous clinical trials to see their effects both short-term and long-term. And if you’re taking a lot of different compounds together, there’s a question of what you are really ingesting and what are the potential effects.”